Drawing for XCELLERATED

USPTO serial 78946718

XCELLERATED

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FINNEGAN, TIMOTHY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XCELLERATED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alan Hammond

IntellevatePO Box 52050Minneapolis, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and compositions for therapeutic use, namely, for expanding, selecting and deleting cells of the immune systems; pharmaceutical preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immune deficiencies; namely, antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres, for promoting a therapeutic effect on the body, namely, by enhancing the immune systemACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 23, 2009MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 23, 2009ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 22, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 29, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 9, 2008NPUBNOTICE OF PUBLICATION—
Mar 27, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 27, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 26, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2008MAILPAPER RECEIVED—
Mar 18, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 21, 2008GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED—
Feb 21, 2008GECGACTION GRANTING REQ FOR RECON E-MAILED—
Feb 21, 2008CNCFACTION CONTINUING FINAL - COMPLETED—
Feb 4, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
Feb 4, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 31, 2008MAILPAPER RECEIVED—
Aug 17, 2007GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 17, 2007GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 17, 2007CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 25, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 25, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 19, 2007ALIEASSIGNED TO LIE—
Jul 2, 2007MAILPAPER RECEIVED—
Jun 28, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 31, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 31, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 2006DOCKASSIGNED TO EXAMINER—
Aug 11, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance